A 28-year-old woman from Kerala presents on day 4 of fever with severe myalgia, arthralgia (especially wrists and ankles), and a maculopapular rash. She has no warning signs of severe dengue. Which investigation is most appropriate to confirm the diagnosis at this stage of illness?

Explanation

## Diagnostic Timing in Dengue, Chikungunya, and Zika **Key Point:** The choice of investigation depends critically on the **day of illness** and the **phase of viremia**. ### Timeline of Diagnostic Tests | Investigation | Optimal Timing | Sensitivity | Notes | |---|---|---|---| | **Viral RT-PCR** | Days 1–5 (acute viremia) | 95–100% | Gold standard during viremia; sensitivity declines after day 5 | | **NS1 antigen** | Days 1–9 (early phase) | 80–95% | Persists longer than viremia; highly reliable days 1–7 | | **IgM antibody** | Days 4–14 (early convalescence) | 80–90% | Begins to appear around day 3–4; peaks by day 7–10 | | **IgG antibody** | Days 7+ (late convalescence) | High | Indicates past infection; not useful for acute diagnosis | | **Hemagglutination inhibition** | Days 10+ (late) | Variable | Older test; less sensitive; rarely used in modern practice | **High-Yield:** On **day 4 of illness**, the patient is in the **febrile/early critical phase** (days 3–7). At this point: - Viremia is **still present but declining** (RT-PCR sensitivity begins to drop) - **NS1 antigen** is **highly detectable and reliable** — it persists in serum from day 1 through day 7–9 - **IgM antibodies** are only beginning to appear and may not yet be at detectable levels in all patients **Clinical Pearl:** NS1 antigen detection by ELISA is the **most appropriate confirmatory test on day 4** because: 1. NS1 antigen is **shed into the bloodstream from day 1 and remains detectable through day 7–9**, making day 4 well within its optimal window 2. It is **highly sensitive (80–95%) and specific** for acute dengue infection 3. It is **widely available, rapid, and cost-effective** in Indian settings (NVBDCP-recommended) 4. It is **recommended by WHO** as the preferred antigen-based test during the febrile phase (days 1–7) 5. IgM, while beginning to appear around day 4, is **not yet reliably positive** in all patients at this early stage — it peaks at days 7–10 ### Why NS1 is Preferred Over IgM on Day 4 Although IgM begins to appear around day 3–4, its sensitivity on day 4 is still suboptimal compared to NS1: - NS1 sensitivity on day 4 is **>85%**, while IgM sensitivity at day 4 is only **~50–60%** - IgM ELISA becomes the preferred test from **day 5–7 onwards**, especially when NS1 may be declining - In endemic areas like Kerala, **NS1 positivity confirms active viremia**, not just past exposure **Mnemonic:** **VIREMIA-ANTIBODY WINDOW** - **V**iremia peaks days 1–3 → RT-PCR best (days 1–5) - **N**S1 antigen persists days 1–9 → NS1 ELISA best during febrile phase - **I**gM appears day 3–4, peaks day 7–10 → IgM ELISA best from day 5 onwards - **R**ecovery phase (day 7+) → IgG appears [cite: WHO Dengue Guidelines 2009; Park 26e Ch 5; Harrison's Principles of Internal Medicine 21e]